Category Archives: Europe

Europe is joining forces against neglected parasitic diseases

The international consortium A-PARADDISE (Anti-Parasitic Drug Discovery in Epigenetics), coordinated by Inserm, has just obtained funds of €6 million from the European Commission to conduct large-scale testing of innovative therapies against four neglected parasitic diseases: schistosomiasis, leishmaniasis, Chagas disease and malaria.

A French researcher attended at the 2014 AAAS meeting in Chicago

European cutting-edge research will be attended at the annual meeting of the American Association for the Advancement of Science (AAAS) in Chicago.

Mechanism elucidated: how smell perception influences food intake

A research team led by Giovanni Marsicano has succeeded in elucidating how the endocannabinoid system controls food intake through its effects on the perception of smells.

ERC: France, the leading country for life sciences in Europe

The European Research Council (ERC) has just awarded Consolidator Grants to 19 French projects in life sciences, thereby placing France at the head of European countries submitting proposals in this area.

Leukemia: mode of action of a targeted treatment clarified

The mechanism of senescence – or premature cell ageing – can have an anticancer effect. This new work, conducted by Hugues de Thé and his team (Paris Diderot University/ Inserm/ CNRS/ AP-HP), was published in Nature Medicine on 12 January 2014.

A good outcome for the CHILD-INNOVAC project: successful test in humans of a nasal vaccine against pertussis

The CHILD-INNOVAC European research programme, coordinated by Inserm, has enabled the development of an innovative vaccine that can be administered intranasally, to combat pertussis, which has shown a resurgence in developed countries in recent years. The research consortium, headed by Camille Locht, Director of the Centre for Infection and Immunity of Lille (a joint Unit involving Inserm, CNRS, Institut Pasteur de Lille and University of Lille Nord de France), today published promising results from Phase I clinical trials of the vaccine in human subjects in the online journal PLOS ONE.

EUCelLEX Project: assessment of the social issues raised by the use of regenerative medicine in Europe

The European EUCelLEX Project (Cell-based regenerative medicine: new challenges for EU legislation and governance), coordinated by Inserm for a three-year period, funding to the tune of €500,000 from the European Union.

Cancer treatment: a step towards personalized chronotherapy

An international study conducted on mice and coordinated by researchers from Inserm, CNRS and Université Paris-Sud[1] has paved the way towards personalized chronotherapy treatments. In an article published in the journal Cancer Research, the team has shown that the timing of optimal tolerance to irinotecan, a widely used anti-cancer drug, varies by 8 hours depending on the sex and genetic background of mice. They then developed a mathematical model that makes it possible to predict, for each animal, the optimal timing for administering the drug.

FIBRO-TARGETS – Europe banks on cardiac fibrosis as a therapeutic target in heart failure

The European Union commits funds to the FIBRO-TARGETS research consortium

Rich or poor in intestinal bacteria: we are not all equal when it comes to obesity-related conditions

They observed that these individuals were deficient in intestinal bacteria (in both quantity and diversity) and were at greater risk of developing cardio-metabolic diseases.

fermer
fermer
RSS Youtube